Guerrero Salvador DO Port Jervis, NY - 12771

Guerrero Salvador DO is categorized under Internal Medicine Doctors in Port Jervis, NY and active since 2010.

Guerrero Salvador DO was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Salvador Guerrero at the company’s single location by writing to 161 East Main St, Port Jervis, New York NY 12771 or by phoning (845) 856-3812. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Guerrero Salvador DO
Contact Person: Salvador Guerrero
Address: 161 East Main St, Port Jervis, New York 12771
Phone Number: (845) 856-3812
Website Address: communitymedicalcare.org
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Guerrero Salvador DO was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Salvador Guerrero for inquiries that concern Guerrero Salvador DO by calling the company number (845) 856-3812, as your correspondence is most welcome. Additionally, the physical location of the single location of Guerrero Salvador DO can be found at the coordinates 41.36795,-74.68261 as well as the street address 161 East Main St in Port Jervis, New York 12771.

For its online presence, you may visit Guerrero Salvador DO’s website at communitymedicalcare.org and engage with its social media outlets through on Twitter and on Facebook.